Corteva (NYSE:CTVA) Hits New 52-Week High – Here’s Why

Corteva, Inc. (NYSE:CTVA) hit a new 52-week high during mid-day trading on Wednesday . The company traded as high as $85.85 and last traded at $85.5690, with a volume of 404426 shares. The stock had previously closed at $84.69.

Analyst Ratings Changes

Several equities research analysts have issued reports on the company. Royal Bank Of Canada raised their target price on Corteva from $95.00 to $97.00 and gave the stock an “outperform” rating in a research note on Thursday, May 7th. Barclays raised their price objective on Corteva from $84.00 to $91.00 and gave the stock an “overweight” rating in a research report on Thursday, June 11th. Morgan Stanley lifted their price target on shares of Corteva from $84.00 to $95.00 and gave the company an “overweight” rating in a research report on Thursday, May 28th. CICC Research boosted their price target on shares of Corteva from $80.00 to $93.00 and gave the company an “outperform” rating in a research note on Wednesday, May 13th. Finally, Wells Fargo & Company increased their price objective on shares of Corteva from $85.00 to $90.00 and gave the stock an “overweight” rating in a research report on Tuesday, April 21st. Fourteen analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the company. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $88.81.

Corteva Price Performance

The company’s 50-day simple moving average is $79.51 and its 200 day simple moving average is $76.54. The company has a market cap of $56.85 billion, a PE ratio of 50.02, a PEG ratio of 2.55 and a beta of 0.57. The company has a debt-to-equity ratio of 0.07, a quick ratio of 1.03 and a current ratio of 1.47.

Corteva (NYSE:CTVA) last announced its quarterly earnings data on Tuesday, May 5th. The company reported $1.50 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.18 by $0.32. The business had revenue of $4.91 billion for the quarter, compared to analysts’ expectations of $4.64 billion. Corteva had a return on equity of 9.95% and a net margin of 6.50%.The company’s revenue for the quarter was up 11.0% compared to the same quarter last year. During the same period last year, the firm earned $1.13 earnings per share. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. On average, sell-side analysts predict that Corteva, Inc. will post 3.72 earnings per share for the current fiscal year.

Corteva Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Monday, June 15th. Shareholders of record on Monday, June 1st were paid a $0.18 dividend. The ex-dividend date was Monday, June 1st. This represents a $0.72 dividend on an annualized basis and a yield of 0.8%. Corteva’s dividend payout ratio (DPR) is currently 42.35%.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently made changes to their positions in CTVA. JPL Wealth Management LLC acquired a new position in Corteva in the third quarter valued at approximately $25,000. Garton & Associates Financial Advisors LLC purchased a new position in Corteva in the fourth quarter valued at approximately $27,000. Bank of Jackson Hole Trust acquired a new stake in Corteva during the fourth quarter worth approximately $28,000. Cornerstone Financial Management LLC purchased a new stake in shares of Corteva during the 4th quarter worth approximately $29,000. Finally, Basepoint Wealth LLC purchased a new stake in shares of Corteva during the 4th quarter worth approximately $30,000. 81.54% of the stock is owned by institutional investors and hedge funds.

Corteva Company Profile

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.